← Back to Search

Coping Strategies for Chronic Pain

N/A
Recruiting
Led By Dokyoung S You, PhD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Prescription opioid use (>3 months)
Chronic pain ( > 3months)
Must not have
Other severe psychiatric conditions (schizophrenia, delusional disorder, psychotic disorder, dissociative disorder, and active suicidality)
Any skin conditions on the hand (pain testing site)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at day 14 (7 days after intervention)
Awards & highlights
No Placebo-Only Group

Summary

This trial will test whether pain catastrophizing is a possible treatment target to reduce prescription opioid craving.

Who is the study for?
This trial is for adults over 18 with chronic pain lasting more than 3 months who have been using prescription opioids. Participants must speak English and have access to email or a smartphone. People with cancer, severe psychiatric conditions, concurrent psychological therapy, skin conditions on the hand, or without technology access cannot join.
What is being tested?
The study tests if 'pain catastrophizing'—a negative mental approach to pain—can be reduced to lessen opioid craving in chronic pain patients. It will also explore if stress hormones and negative emotions are part of why this might work.
What are the potential side effects?
Since this intervention involves coping statements rather than medication, traditional side effects like those seen with drugs are not expected. However, participants may experience emotional discomfort when addressing their thoughts about pain.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been using prescribed opioids for more than 3 months.
Select...
I have been experiencing pain for more than 3 months.
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not have severe psychiatric conditions like schizophrenia or active thoughts of suicide.
Select...
I have a skin condition on my hand.
Select...
I am currently diagnosed with cancer.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at day 14 (7 days after intervention)
This trial's timeline: 3 weeks for screening, Varies for treatment, and at day 14 (7 days after intervention) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
craving
Secondary study objectives
Anxiety symptoms
Cortisol
Depression symptoms
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Coping statementExperimental Treatment1 Intervention
Daily practice of pain coping statements for 7 days
Group II: ControlActive Control1 Intervention
No instruction about pain coping statement.

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,469 Previous Clinical Trials
17,501,591 Total Patients Enrolled
39 Trials studying Chronic Pain
9,338 Patients Enrolled for Chronic Pain
National Institute on Drug Abuse (NIDA)NIH
2,582 Previous Clinical Trials
3,326,884 Total Patients Enrolled
64 Trials studying Chronic Pain
84,418 Patients Enrolled for Chronic Pain
Dokyoung S You, PhDPrincipal InvestigatorStanford University

Media Library

Coping Statement Clinical Trial Eligibility Overview. Trial Name: NCT04097743 — N/A
Chronic Pain Research Study Groups: Coping statement, Control
Chronic Pain Clinical Trial 2023: Coping Statement Highlights & Side Effects. Trial Name: NCT04097743 — N/A
Coping Statement 2023 Treatment Timeline for Medical Study. Trial Name: NCT04097743 — N/A
~7 spots leftby Jan 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top